Next-Generation Biomarker Panels: Precision Monitoring in Veterinary Practice
The Diagnostic Gap: Why Single Biomarkers Fall Short in Modern PracticeFor decades, veterinary diagnostics relied on single-analyte measurements—a cortisol level here, a thyroid hormone there. These snapshots offered limited context, often missing early disease trajectories or masking concurrent pathologies. As caseloads grow more complex, with aging pet populations and multimorbid patients, the limitations of single-marker testing become stark. A single elevated creatinine may indicate renal disease, but without parallel markers like SDMA, symmetric dimethylarginine, or urinary protein-to-creatinine ratio, staging and prognosis remain imprecise. The core problem is biological noise: individual biomarkers fluctuate due to diet, stress, circadian rhythms, or transient illness, leading to false positives or missed diagnoses.Next-generation panels address this by integrating multiple analytes into a single assay, providing a multidimensional view of organ function, inflammation, and metabolic status. These panels are not merely additive; they exploit correlations and ratios—like the neutrophil-to-lymphocyte ratio for systemic inflammation—to reveal patterns invisible